Andrea Vambutas
Northwell Health
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Andrea Vambutas as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:57 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT03587701 · Effects of Anakinra in Subjects With Corticosteroid-resistant/Intolerant Meniere's Disease and Autoimmune Inner Ear DiseaseNorthwell Health · recruiting · Autoimmune Inner Ear Disease, Meniere's Disease · principal investigator
- Ph1/Ph2NCT02414152 · Study of the Effects of Anakinra in Corticosteroid-resistant Subjects With Sudden Sensorineural Hearing LossAndrea Vambutas · terminated · Hearing Loss, Sudden · principal investigator
- Ph1/Ph2NCT01267994 · A Clinical Trial of Anakinra for Steroid-Resistant Autoimmune Inner Ear DiseaseAndrea Vambutas · completed · Sensorineural Hearing Loss, Autoimmune Inner Ear Disease · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 07:57 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 5 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- A phase I clinical trial of Anakinra for Steroid-Resistant AIEDR33DC011827 · NIDCD · FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH · fiscal years 2012 to 2015 · $101 awarded in 2015Grant number is on one of their registry trials
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 07:57 UTC. The ranking covers the 200 most relevant of 1 PubMed records, and a shared surname and initials can bring in a namesake. All 1 on PubMed
- Early efficacy trial of anakinra in corticosteroid-resistant autoimmune inner ear disease.J Clin Invest · 201456 citationsRCR 2.1